News brief
On 2026-07-16, according to Xiniu Data, Lidejiankang completed Pre-Series A financing, raising RMB 100 million. Investors were lead investor Tuojing Technology, participating investor Jiadao Capital, participating investor Zhongkechuangxing. The company is a developer of AI life sciences instruments and intelligent biomanufacturing equipment.
Connected profiles
Explore
Sources · 0Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
No source links are available for this profile.
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
2026年7月16日，据烯牛数据报道，利德健康完成Pre-A轮融资，金额1亿人民币。投资方为拓荆科技领投，嘉道资本、中科创星跟投。该公司为AI生命科学仪器和生物智造装备研发商。